Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Expedeon Signs Supply Deal for Colloidal Gold With Reszon Diagnostics

Expedeon Signs Supply Deal for Colloidal Gold With Reszon Diagnostics

Sep 27, 2018
|
staff reporter

NEW YORK (360Dx) — Expedeon said today that it has signed a three-year supply agreement for its colloidal gold with Malaysia-based Reszon Diagnostics International.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Infectious Disease

  1. COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

    Premium

  2. Mass Spec Struggles to Demonstrate Utility as Platform for SARS-CoV-2 Dx

    Premium

  3. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  4. Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

    Premium

  5. Israeli Diagnostics Firm NanoSynex Aiming for European Market Entry for AMR Test by 2023

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.